Bgm Group Ltd Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Due to inventory build up in the fourth quarter 2024, Bgm Group Ltd's inventory turnover ratio sequentially decreased to 2.34 in the fourth quarter 2024, unsurprisingly, as the Bgm Group Ltd markets continue to deteriorate, and BGM's faces growing challenges to bring down its inventories. Bgm Group Ltd's average inventory processing period in the Sep 30 2024 quarter, has increased to 156 days, from 40 days, in the 0 quarter.

Within Healthcare sector 61 other companies have achieved higher inventory turnover ratio. While Inventory turnover ratio total ranking has improved so far during the IV Quarter 2024, to 918, from total ranking in the third quarter 2024 at 921.

BGM Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Bgm Group Ltd Market Share?

What is Inventory Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Inventory Turnover▼

None ▼

Inventory Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

BGM Inventory Turnover Ratio	(Sep 30 2024) IV. Quarter	0 III. Quarter	0 II. Quarter	0 I. Quarter	(Sep 30 2023) IV. Quarter
Y / Y Inventory Growth	298.11 %	650.54 %	1.17 %	172.99 %	1.17 %
Y / Y Cost of Sales Growth	-54.55 %	-	-	-	-24.95 %
Inventory Turnover Ratio (TTM)	2.34	-	-	-	14.9
BGM's Total Ranking	# 918	# 921	# 0	# 0	# 0
Average inventory processing period	156	-	-	-	24
Seq. Inventory Growth	202.41 %	31.64 %	108.85 %	-52.12 %	470.13 %
Seq. Cost of Sales Growth	-	-	-	-	-

Inventory Turnover Ratio Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	# 14
Healthcare Sector	# 62
Overall Market	# 918

Inventory Turnover Ratio Statistics
High	Average	Low
15.45	8.85	4.12
(Sep 30 2023)		(Sep 30 2021)

BGM Company Profile >> Back to BGM Efficiency Comparisons >> Compare BGM Inventory Turnover Ratio to its Competitors

Financial Statements
Bgm Group Ltd's Inventories	$ 20 Millions	Visit BGM's Balance sheet
Bgm Group Ltd's Cost of Revenues TTM	$ 20 Millions	Visit BGM's Income Statement
What are BGM's Sales?		Visit BGM's Sales by Segment

Other Inventory Turnover Ratios
Bgm Group Ltd's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Major Pharmaceutical Preparations Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
BGM's Inventory Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for BGM's Competitors
Inventory Turnover Ratio for BGM's Suppliers
Inventory Turnover Ratio for BGM's Customers

You may also want to know
BGM's Sales Growth Rates	BGM's Pe Price to earnings ratio	BGM's Receivables Turnover Ratio	BGM's Stock Quote
BGM's Net Income Growth Rates	BGM's Ps Price to Sales ratio	BGM's Sales per Employee	BGM's Asset Turnover Ratio
BGM's Net Margin	BGM's Pb Price to Book ratio	BGM's Financial Strength Ratios	BGM's Dividend Payout Ratio

Companies with similar Inventory Turnover Ratio for the quarter ending Sep 30 2024, within Healthcare Sector	Inventory Turnover Ratio	Cost of revenues at quarter ending Sep 30 2024	Inventories at quarter ending Sep 30 2024
International Stem Cell Corporation	2.73	$ 3.637 Millions	$ 1 Millions
Abbott Laboratories	2.71	$ 18,320.000 Millions	$ 6,756 Millions
Tenon Medical Inc	2.68	$ 1.558 Millions	$ 1 Millions
Rigel Pharmaceuticals Inc	2.67	$ 16.648 Millions	$ 6 Millions
Pro dex Inc	2.67	$ 40.755 Millions	$ 15 Millions
Zynex inc	2.66	$ 39.718 Millions	$ 15 Millions
Nexgel Inc	2.65	$ 3.913 Millions	$ 1 Millions
Dariohealth Corp	2.64	$ 13.102 Millions	$ 5 Millions
Accelerate Diagnostics Inc	2.63	$ 8.394 Millions	$ 3 Millions
Dexcom Inc	2.63	$ 1,514.200 Millions	$ 576 Millions
Phibro Animal Health Corporation	2.61	$ 717.937 Millions	$ 275 Millions
Neuronetics Inc	2.60	$ 16.856 Millions	$ 6 Millions
Urogen Pharma Ltd	2.60	$ 8.696 Millions	$ 3 Millions
Livanova Plc	2.58	$ 397.980 Millions	$ 155 Millions
Biolase Inc	2.56	$ 27.870 Millions	$ 11 Millions
Aquestive Therapeutics Inc	2.53	$ 18.031 Millions	$ 7 Millions
Lifevantage Corp	2.53	$ 40.000 Millions	$ 16 Millions
Quidelortho Corp	2.52	$ 1,476.000 Millions	$ 585 Millions
Neogen Corporation	2.51	$ 459.167 Millions	$ 183 Millions
Co diagnostics Inc	2.50	$ 3.712 Millions	$ 1 Millions
Perrigo Company Plc	2.49	$ 2,808.000 Millions	$ 1,128 Millions
Marizyme Inc	2.47	$ 0.058 Millions	$ 0 Millions
Encision Inc	2.43	$ 3.311 Millions	$ 1 Millions
Biomerica Inc	2.42	$ 5.021 Millions	$ 2 Millions
Revvity Inc	2.40	$ 990.905 Millions	$ 412 Millions
Merck and Co Inc	2.39	$ 15,277.000 Millions	$ 6,395 Millions
Evofem Biosciences Inc	2.37	$ 3.276 Millions	$ 1 Millions
United Therapeutics Corporation	2.37	$ 304.800 Millions	$ 129 Millions
Viatris Inc	2.36	$ 9,043.400 Millions	$ 3,830 Millions
Ocular Therapeutix Inc	2.35	$ 5.782 Millions	$ 2 Millions

Date modified: 2026-07-23T01:54:12+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.